Brought to you by 
Dr. Reddy's, 7TM Pharma ally in metabolic disorders
25 Mar 2008
Executive Summary
Dr. Reddy's Laboratories and 7TM Pharma (focused on metabolic diseases) will ally in the discovery and development of compounds aimed at G protein-coupled receptor (GPCR) targets for undisclosed metabolic disorders.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dr. Reddy's, 7TM Pharma ally in metabolic disorders
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice